Gossamer Bio, Inc. GOSS
9.45 USD -0.93 -8.96%
At close
9.52 +0.07 +0.74%
Pre-market · Nov 3, 4:00 AM ET
8.29 52-week range 309.60
- YTD
- -96.19%
- 1 year
- -95.18%
- Open
- 10.30
- Prev close
- 10.38
- Mkt cap
- 57.80M
- Vol
- 190.79K
- Avg vol
- 259.25K
- EPS
- -52.80
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.30
- High
- 10.35
- Forward P/E
- -0.69
- Beta
- 2.00
- Short ratio
- 3.80
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 13.50
- 200-d avg
- 78.36
- 1y target
- 132.48
MAX chart
Chart tools
Chart is warming up
The all-time price history for GOSS has not been loaded yet. Try again in a moment.
Altman Z-Score
-35.69 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -4.2×
P/S 14.6×
P/B -5.8×
P/FCF -4.1×
EV/EBITDA -5.5×
EV/Sales 18.0×
FCF Yield -24.2%
Gross Margin 97.9%
Operating Margin -336.8%
Net Margin -351.5%
ROE 138.8%
ROIC -148.7%
ROA -98.9%
Revenue -57.7%
Operating Income -172.5%
EPS (diluted) -198.3%
Free Cash Flow -4840.7%
Current Ratio 2.6×
Quick Ratio 2.6×
Debt / Equity -1.7×
Net Debt / EBITDA -1.0×
Interest Coverage -14.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31